Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) Stock Price & Growth Analysis

Quote Panel

Updated October 4, 2024

1W 0.00 % 1M 1.03 % 3M 2.89 % 1Y 15.78 %

Key Metrics

Market Cap
1.58B
Shares Outstanding
61.58M
Share in Float
52.66M
Dividende
2.15624

Earning Date
No Data
Price Target
25.61
Average Volume
5571
Beta
0.14146519

Range
22.05-25.72
Industry
Medical - Pharmaceuticals
Website
http://www.harrowinc.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

10.56x

P/S Ratio

28.14x

P/B Ratio

3.2

Debt/Equity

-21.8%

Net Margin

$0.0

EPS

How HROWL compares to sector?

P/E Ratio

Relative Strength

HROWL

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

NA
vs NA

Q2.22

N/A

NA
vs NA

Q3.22

N/A

NA
vs NA

Q4.22

N/A

-0.00
vs NA

Q1.23

N/A

-0.22
vs NA

Q2.23

N/A

-0.14
vs NA

Q3.23

N/A

-0.13
vs NA

Q4.23

N/A

NA
vs -0.00

Q1.24

N/A

NA
vs -0.22

Q2.24

N/A

NA
vs -0.14

Sales Growth

YoY

Current

Estimates

Q1.22

+43%

22.1M vs 15.4M

Q2.22

+29%

23.3M vs 18.1M

Q3.22

+22%

22.8M vs 18.7M

Q4.22

+1%

20.3M vs 20.2M

Q1.23

+18%

26.1M vs 22.1M

Q2.23

+44%

33.5M vs 23.3M

Q3.23

+50%

34.3M vs 22.8M

Q4.23

+79%

36.4M vs 20.3M

Q1.24

+33%

34.6M vs 26.1M

Q2.24

+46%

48.9M vs 33.5M

Return on Equity

QoQ

Q3.22

-531%

-5.31
vs -1.09

Q4.22

+4%

0.04
vs -5.31

Q1.23

-31%

-0.31
vs 0.04

Q2.23

-19%

-0.19
vs -0.31

Q3.23

-6%

-0.06
vs -0.19

Q4.23

-13%

-0.13
vs -0.06

Q1.24

-23%

-0.23
vs -0.13

Q2.24

-11%

-0.11
vs -0.23

Institutionnal Ownership

Company Description

N/A

10.56x

28.14x

3.2

-21.8%

$0.0

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!